北美肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型（维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等）和分销渠道（药店、零售渠道、在线渠道等）
老年人口激增推动北美肌肉减少症治疗市场发展
老年人口易患肌肉减少症、骨科疾病、代谢疾病和神经系统疾病等。肌肉减少症是一种老年病，其特征是骨骼肌的质量和强度逐渐下降。它与不良健康结果的更高风险有关，例如跌倒、残疾、机构化、生活质量差和死亡。发达国家的老年人口正在迅速增加。根据世界卫生组织（WHO）的数据，到2050年，全球老龄人口可能会从2019年的约10亿增加到约21亿。此外，根据2020年人口普查，在1920年至2020年的100年间，美国65岁及以上人口的增长速度约为总人口的5倍。2020年，老年人口数量达到5580万，占美国总人口的16.8％。
衰老导致肌肉质量的下降，这是身体成分的主要变化之一。老年人的食物消费大幅下降是导致肌肉质量下降的关键因素之一。根据美国国家医学图书馆的数据，50-60 岁年龄段的人每年会损失近 1.5% 的肌肉力量，而 60 岁以后每年会损失 1-2% 的肌肉质量。与一般人群相比，老年患者的肌肉减少症患病率更高。根据 2023 年 6 月发表在 Elsevier 上的一篇文章，肌肉减少症的患病率从糖尿病患者的 18% 到无法治愈的食道癌患者的 66% 不等。因此，老年人口的增加对肌肉减少症治疗市场的增长做出了重大贡献。
北美肌肉减少症治疗市场概览
北美的肌肉减少症治疗市场分为美国、加拿大和墨西哥。2022 年，北美占全球市场的最大份额。北美肌肉减少症治疗市场的增长归因于营养补充剂在治疗中的应用日益增多。此外，老年人群中维生素 B12 和维生素 D 缺乏症病例不断增加，骨科疾病患病率飙升，这也推动了该地区市场的发展。
肌肉减少症的患病率因年龄和性别而异；在美国，居住在辅助生活设施或社区的老年人患上这种疾病的风险更高。根据美国国立卫生研究院的数据，2019 年，美国肌肉减少症患者的预期住院费用为 404 亿美元。肌肉减少症患者每年平均比肌肉质量和功能正常的人多支付 2,315 美元的医院就诊费用；他们住院的可能性几乎是没有肌肉减少症的人的两倍。此外，骨骼肌损失减少 10% 可以预防可能出现的肌肉减少症合并症，并每年为美国节省约 10 亿美元的医疗费用。
北美肌肉减少症治疗市场收入及预测至 2030 年（百万美元）
北美肌肉减少症治疗市场细分
北美肌肉减少症治疗市场分为治疗类型、分销渠道和国家。
根据治疗类型，北美肌肉减少症治疗市场细分为维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等。维生素 D 和钙补充剂部分在 2022 年占据了北美肌肉减少症治疗市场的最大份额。
在分销渠道方面，北美肌肉减少症治疗市场细分为药店、零售渠道、在线渠道和其他。药店部分在 2022 年占据了北美肌肉减少症治疗市场的最大份额。
按国家/地区划分，北美肌肉减少症治疗市场细分为美国、加拿大和墨西哥。 2022 年，美国占据了北美肌肉减少症治疗市场的主导份额。
雅培实验室、拜耳公司、Metagenics LLC、雀巢健康科学公司、诺华公司、辉瑞公司、赛诺菲公司、安利公司、葛兰素史克公司和 Makers Nutrition LLC 是北美肌肉减少症治疗市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Sarcopenia Treatment Market - Key Industry Dynamics
4.1 North America Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - North America Market Analysis
5.1 North America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 North America Sarcopenia Treatment Market Forecast and Analysis
6. North America Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. North America Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. North America Sarcopenia Treatment Market - Country Analysis
8.1 North America
8.1.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Makers Nutrition LLC
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. North America Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - By Treatment Type
Table 5. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 15. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. North America Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. North America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. North America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. North America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. North America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Metagenics LLC
4. Nestle Health Science SA
5. Novartis AG
6. Pfizer Inc
7. Sanofi SA
8. Amway Corp
9. GSK Plc
10. Makers Nutrition LLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.